- Report
- September 2026
- 271 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 381 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 272 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 193 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 131 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 276 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 144 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Drug Pipelines
- September 2026
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- September 2026
- 200 Pages
Global
From €7148EUR$7,990USD£6,124GBP
- Report
- September 2026
- 120 Pages
Global
From €7148EUR$7,990USD£6,124GBP
- Report
- July 2026
- 147 Pages
Global
From €7148EUR$7,990USD£6,124GBP
- Report
- July 2026
- 200 Pages
Global
From €7148EUR$7,990USD£6,124GBP
- Report
- May 2026
- 30 Pages
Global
From €2460EUR$2,750USD£2,108GBP
- Clinical Trials
- May 2026
- 80 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Report
- December 2025
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- December 2025
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- November 2025
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Report
- November 2025
- 200 Pages
Global
From €7112EUR$7,950USD£6,093GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Drug Pipelines
- May 2026
- 180 Pages
Global
From €1789EUR$2,000USD£1,533GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more